Unity Biotechnology, Inc. Accrued Liabilities, Current
Unity Biotechnology, Inc. had Accrued Liabilities, Current of $6.06 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-04-22
- 2025-03-31: Accrued Liabilities, Current $6.06M.
- 2024-12-31: Accrued Liabilities, Current $6.17M.
- 2024-09-30: Accrued Liabilities, Current $5.28M.
- 2024-06-30: Accrued Liabilities, Current $5.98M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-03-31 | $6.06M 10-Q · filed 2025-04-22 | |
| 2024-12-31 | $6.17M 10-Q · filed 2025-04-22 | |
| 2024-09-30 | $5.28M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $5.98M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $5.18M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.62M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $5.26M 10-K · filed 2024-04-15 | |
| 2023-06-30 | $5.42M 10-K · filed 2024-04-15 | |
| 2023-03-31 | $5.34M 10-K · filed 2024-04-15 | |
| 2022-12-31 | $5.33M 10-K · filed 2024-04-15 | |
| 2022-09-30 | $5.32M 10-K · filed 2024-04-15 | $4.59M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.60M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $6.69M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $6.37M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $6.86M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $8.88M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $6.46M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $6.55M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $6.94M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $6.25M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $7.42M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $5.00M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $4.91M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $4.84M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $4.92M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $4.99M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $4.62M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $4.86M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $3.34M 10-K · filed 2019-03-06 |